Author

H. Lulka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 4 Research Focus:cancer & tumor microenvironment· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

L. Buscail· 3 shared P. Cordelier· 3 shared P. Garcin· 2 shared A. Couvelard· 1 shared C. Valle· 1 shared C. Vargas· 1 shared D. Pagan· 1 shared D. Varry· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

L. Buscail

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer

O. Barbey, H. Lulka, N. Hanoun, H. Belhadj, F. Vernejoul, G. Cambois, M. Tiraby, L. Buscail, F. Gross, P. Cordelier

This paper develops a non-viral gene therapy, CYL-02, for pancreatic cancer, demonstrating its safety, biodistribution, and therapeutic efficacy when combined with gemcitabine.

Molecular Therapy - Methods & Clinical Development · Jun 1, 2023Peer-reviewedCancer Biology

Minute virus of mice is oncolytic for pancreatic cancer cells with mesenchymal phenotype

P. Garcin, H. Lulka, M. Vienne, N. Dusetti, L. Buscail, P. Cordelier

This study shows that the minute virus of mice (MVMp) selectively targets and kills mesenchymal, basal-like pancreatic cancer cells, both in vitro and in vivo, offering a potential precision therapy for aggressive pancreatic tumors.

bioRxiv · Apr 11, 2023 · PreprintCancer Biology

The Loss of the E3 ubiquitin ligase TRIP12 inhibits Pancreatic Acinar Cell Plasticity and Tumor Cell Metastatic Capacity

M. Brunet, C. Vargas, M. Fanjul, L. Pieruccioni, D. Varry, G. Labrousse, H. Lulka, F. Capilla, A. Couvelard, V. Gigoux, J. Guillermet-Guibert, J. Torrisani, M. Dufresne

This paper shows that TRIP12 loss inhibits pancreatic acinar cell plasticity and tumor metastasis by affecting Claudin18.2 expression and ADM.

bioRxiv · Mar 8, 2023 · PreprintCancer Biology

The antitumoral activity of TLR7 ligands is corrupted by the microenvironment of pancreatic tumors

M. Rouanet, H. Lulka, P. Garcin, M. Sramek, D. Pagan, C. Valle, E. Sarot, V. Pancaldi, F. Lopez, L. Buscail, P. Cordelier

This study shows that TLR7 ligands inhibit pancreatic cancer cell growth in vitro but promote tumor growth in immunocompetent mice due to increased tumor-promoting macrophages.

bioRxiv · Mar 5, 2020Cancer Biology